NIGMS Director’s Update – June 10
- Registration Closed
This webinar has been rescheduled to June 19, 1-2 pm ET. Due to the sudden change, we have had to switch the platform of the webinar to WebEx. All registrants for this webinar will automatically be invited to the WebEx webinar. If you have not yet registered, please email Emily Outtarac at firstname.lastname@example.org to be added to the Outlook invitation.
On June 10, members of the STEM community participated in a day of action called #ShutDownSTEM, which was intended to draw attention to the impact of systemic racism and injustice on Black people in STEM and academia. The AAMC rescheduled this Community Forum out of respect for this day of action, and we encourage all participants to take a pause and reflect on what each of us can do to move forward together.
Join Jon Lorsch, PhD, Director of the National Institute of General Medical Sciences (NIGMS), for an update on key NIGMS issues for the extramural research and research training community. Dr. Lorsch will address:
- NIGMS support of faculty and trainees during the COVID-19 pandemic
- Progress of MIRA (R35) awards for early-career and established investigators
- Update on revised NIGMS T32 training programs
- Support for regional facilities and lab safety in training environments
Dr. Lorsch welcomes discussion during a question and answer period to follow the presentation.
You may also submit questions ahead of time to Amanda Field, PhD, AAMC Senior Science Policy Specialist, at email@example.com.
The AAMC looks forward to providing this platform for interaction with the GREAT and GRAND communities on these and future topics. Please send topic suggestions to Amanda Field (above).
Jon R. Lorsch, PhD
Director of the NIH National Institute of General Medical Sciences (NIGMS)
Jon Lorsch became the director of NIGMS in August 2013. In this position, Lorsch oversees the Institute's $2.9 billion budget, which supports basic research that increases understanding of biological processes and lays the foundation for advances in disease diagnosis, treatment, and prevention. NIGMS supports more than 3,000 investigators and 5,000 research grants–around 11 percent of the total number of research grants funded by NIH as a whole. Additionally, NIGMS supports around 26 percent of the NRSA trainees who receive assistance from NIH.